Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes.
Small interfering RNA (siRNA) targeted therapeutics (STT) offers a compelling alternative to tradition medications for treatment of genetic diseases by providing a means to silence the expression of specific aberrant proteins, through interference at the expression level. The perceived advantage of...
Main Authors: | Elena Nicolì, Marie Isabel Syga, Michela Bosetti, V Prasad Shastri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4391875?pdf=render |
Similar Items
-
Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
by: Jean Baptiste Gossart, et al.
Published: (2017-07-01) -
Size- and Surface- Dual Engineered Small Polyplexes for Efficiently Targeting Delivery of siRNA
by: Shuang Liu, et al.
Published: (2021-05-01) -
In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes
by: Arun R. Shrivats, et al.
Published: (2015-07-01) -
Specific and efficient in vivo delivery of DNA and siRNA by polyethylenimine and its derivatives
by: Fortune, Jennifer A
Published: (2011) -
Integration of Polylactide into Polyethylenimine Facilitates the Safe and Effective Intracellular siRNA Delivery
by: Guo-Bin Ding, et al.
Published: (2020-02-01)